Nathaniel Calloway
Director/Board Member bei ANEBULO PHARMACEUTICALS, INC.
Vermögen: 149 046 $ am 31.03.2024
Profil
Nathaniel Calloway is currently the Director at Lifecore Biomedical, Inc., an Independent Director at Anebulo Pharmaceuticals, Inc., and a Healthcare Analyst at 22NW LP.
Previously, he worked as an Analyst at Edison Investment Research, Inc. from 2015 to 2021.
Dr. Calloway holds a graduate degree from The Trustees of Columbia University in The City of New York, a doctorate degree from Cornell University, and an undergraduate degree from The University of North Carolina at Chapel Hill (conferred in 2004).
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.02.2024 | 28 069 ( 0,09% ) | 149 046 $ | 31.03.2024 |
Aktive Positionen von Nathaniel Calloway
| Unternehmen | Position | Beginn |
|---|---|---|
| ANEBULO PHARMACEUTICALS, INC. | Director/Board Member | 01.11.2022 |
| LIFECORE BIOMEDICAL, INC. | Director/Board Member | 09.01.2023 |
22NW LP
 22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Analyst-Equity | 01.06.2021 |
Ehemalige bekannte Positionen von Nathaniel Calloway
| Unternehmen | Position | Ende |
|---|---|---|
Edison Investment Research, Inc.
 Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Analyst-Equity | 01.06.2021 |
Ausbildung von Nathaniel Calloway
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Cornell University | Doctorate Degree |
| The University of North Carolina at Chapel Hill | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| LIFECORE BIOMEDICAL, INC. | Health Technology |
| ANEBULO PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Edison Investment Research, Inc.
Edison Investment Research, Inc. Investment ManagersFinance Edison Investment Research, Inc. is an investment research firm located in New York City. The firm is a subsidiary of Edison Investment Research Ltd., a leading international investment research firm. The firm writes on more than 350 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison's research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. | Finance |
22NW LP
22NW LP Investment ManagersFinance 22NW LP is an independent registered hedge fund manager headquartered in Seattle, Washington. The firm was founded by Aron English in 2015. It provides investment advice and management to a pooled investment vehicle. | Finance |
